Ewing sarcoma is the second most common bone cancer in children and young adults but unfortunately is not very responsive to conventional chemotherapy. Novel combination of CDK inhibitor and PARP inhibitors have been found to be very effective in controlling growth of Ewing sarcoma cells and could be potential game changer in treatment of this disease.
Disclaimer - All information and content on this site are for information and educational purposes only. The information should not be used for either diagnosis or treatment or both for any health related problem or disease. Always seek the advice of a qualified physician for medical diagnosis and treatment. Full Disclaimer